Ocugen preps filings for COVID-19 vaccine Covaxin on new dataArmed with new data from its development partner Bharat Biotech, Ocugen is planning to press ahead with plans Share XOcugen preps filings for COVID-19 vaccine Covaxin on new datahttps://pharmaphorum.com/news/ocugen-preps-filings-for-covid-19-vaccine-covaxin-on-new-data/
Ocugen gets a black eye as FDA denies emergency OK for COVID jabOcugen is the first company to be affected by the FDA’s recent decision to raise the bar on Share XOcugen gets a black eye as FDA denies emergency OK for COVID jabhttps://pharmaphorum.com/news/ocugen-gets-a-black-eye-as-fda-denies-emergency-ok-for-covid-jab/
Ocugen, Histogenics merge to form eye disease specialistUS biotechs Ocugen and Histogenics have announced plans to merge, creating a specialist in drugs and gene therapies Share XOcugen, Histogenics merge to form eye disease specialisthttps://pharmaphorum.com/news/ocugen-histogenics-merge-to-form-eye-disease-specialist/
